Search

Author/Creator Mercuri, Michele F

1. Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial. Issue 2 (19th November 2018)

Authors:
Steffel, Jan; Ruff, Christian T; Braunwald, Eugene; Hamershock, Rose A; Murphy, Sabina A; Nieminen, Markku; Lanz, Hans-Joachim; Mercuri, Michele F; Peterson, Nancy; Antman, Elliott M; Giugliano, Robert P
Journal:
Europace
Issue:
Volume 21:Issue 2(2019)
Page Start:
306
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial. Issue 8 (August 2016)

Authors:
Raskob, Gary E; van Es, Nick; Segers, Annelise; Angchaisuksiri, Pantep; Oh, Doyeun; Boda, Zoltan; Lyons, Roger M; Meijer, Karina; Gudz, Ivan; Weitz, Jeffrey I; Zhang, George; Lanz, Hans; Mercuri, Michele F; Büller, Harry R
Journal:
Lancet
Issue:
Volume 3:Issue 8(2016)
Page Start:
e379
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Issue 2 (1st March 2019)

Authors:
Zelniker, Thomas A; Ruff, Christian T; Wiviott, Stephen D; Blanc, Jean-Jacques; Cappato, Riccardo; Nordio, Francesco; Mercuri, Michele F; Lanz, Hans; Antman, Elliott M; Braunwald, Eugene; Giugliano, Robert P
Journal:
European heart journal
Issue:
Volume 8:Issue 2(2019)
Page Start:
176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF–TIMI 48. Issue 2 (March 2019)

Authors:
Zelniker, Thomas A; Ruff, Christian T; Wiviott, Stephen D; Blanc, Jean-Jacques; Cappato, Riccardo; Nordio, Francesco; Mercuri, Michele F; Lanz, Hans; Antman, Elliott M; Braunwald, Eugene; Giugliano, Robert P
Journal:
European heart journal
Issue:
Volume 8:Issue 2(2019)
Page Start:
176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. Issue 10055 (22nd October 2016)

Authors:
Goette, Andreas; Merino, Jose L; Ezekowitz, Michael D; Zamoryakhin, Dmitry; Melino, Michael; Jin, James; Mercuri, Michele F; Grosso, Michael A; Fernandez, Victor; Al-Saady, Naab; Pelekh, Natalya; Merkely, Bela; Zenin, Sergey; Kushnir, Mykola; Spinar, Jindrich; Batushkin, Valeriy; de Groot, Joris ...
Journal:
Lancet
Issue:
Volume 388:Issue 10055(2016)
Page Start:
1995
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Issue 9984 (6th June 2015)

Authors:
Mega, Jessica L; Walker, Joseph R; Ruff, Christian T; Vandell, Alexander G; Nordio, Francesco; Deenadayalu, Naveen; Murphy, Sabina A; Lee, James; Mercuri, Michele F; Giugliano, Robert P; Antman, Elliott M; Braunwald, Eugene; Sabatine, Marc S
Journal:
Lancet
Issue:
Volume 385:Issue 9984(2015)
Page Start:
2280
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗